Diana Ernst

Olezarsen for Familial Chylomicronemia Syndrome Sotagliflozin for Patients With Type 1 Diabetes and CKD Datopotamab Deruxtecan for Advanced Nonsquamous NSCLC

The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for reproxalap for the treatment of the signs and symptoms of dry eye disease.

Patients should be selected for treatment based on the presence of a KMT2A translocation.

Clonazepam ODT, USP (C-IV) 2mg; NDC# 49884-310-02; Lot# 550176501, 550176601. Clonazepam ODT, USP (C-IV) 0.125mg; NDC# 49884-306-02; Lot# 550174101.

First and only in-home test for syphilis now available to consumers through major retailers and public health: NOWDiagnostics launches First To Know

Tryvio TM (aprocitentan) is now available for the treatment of hypertension in combination with other antihypertensive drugs, to lower blood pressure (BP) in adult patients who are not adequately controlled on other drugs.

The investigational product, known as MELT-300, is administered sublingually and dissolves on the tongue within 3 seconds. The randomized, double-blind, three-arm, phase 3 study (ClinicalTrials.gov Identifier:

Jazz Pharmaceuticals announces US FDA approval of Ziihera ®

The Food and Drug Administration has granted Orphan Drug designation to KIND Pharmaceutical’s AND017 for the treatment of sickle cell disease (SCD).

Zevra Therapeutics announces US commercial availability of Miplyffa™ (arimoclomol) for treatment of Niemann-Pick disease type C. News release. Zevra Therapeutics. November 21, 2024.